Blake Borgeson sold $159K of RXRX stock

Blake Borgeson, Dir of Recursion Pharmaceuticals, Inc. (RXRX), sold 40,000 shares of RXRX stock worth $159K, per an SEC Form 4 filed Jul 9, 2026.

The sale was pre-arranged (a 10b5-1 plan or an option exercise), not a fresh decision.

The trade happened on Jul 7, 2026, 2 days before it was made public.

RXRX has moved -0.9% since the trade date, from $3.84 to $3.81 (Nov 9, 2026 close).